First clinical proof that genotypes determine if Alzheimer's drugs will work: Researchers' insights into a target that succeeded in animals but failed in humans reveal a new paradigm for screening Alzheimer's drugs

www.sciencedaily.com

Researchers have determined that a human gene present in 75% of the population is a key reason why a class of drugs for Alzheimer's disease seemed promising in animal studies only to fail in human studies.

  • 0 Likes

  • 0 Comments